About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Six-Month Prospective Follow-Up Study of WB001 | Clinical Trials | Clareo Health

Back to clinical trial search

WITHDRAWNNCT05693792

A Six-Month Prospective Follow-Up Study of WB001

This study is a 6-month follow-up study to WB001-001 conducted to assess and evaluate the durability of the effect of {WB001+TAU} beyond the 8-week treatment period.

Lead sponsor: Woebot Health•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Woebot Health

This study is a 6-month prospective, observational follow-up study to the WB001-001 trial. Participants will be a convenience sample of those enrolled in the WB001-001 parent trial who consent to participate in a follow-up study at baseline for WB001-001. After completion of WB001-001's EOT assessment, those consenting to participate in the current study will be screened to confirm eligibility. Eligible participants will complete six assessment batteries (patient-reported outcomes \[PROs\]) on a monthly basis for a 6-month observation period.

Age

22 - 45 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•1. Must have prior enrollment in the WB001-001 trial and completion of Week 8/EOT
•2. Must be willing and able to comply with all study procedures

Exclusion Criteria

•1\. Documented AE or SAE at WB001-001 Week 8 related to participant safety, by Investigator judgement

Related studies

The Mom and Infant Outcomes (MOMI) Study

NCT06277661 · Postpartum Depression, Postpartum Anxiety, and more

Admission to Kangaroo Mother Care (KMC) Ward and Maternal Postpartum Depression

NCT06545760 · Low Birth Weight, Kangaroo Mother Care, and more

Evaluating the Effectiveness of an Internet-based Therapy (iCARE) to Treat Symptoms of Postpartum Depression

NCT07384273 · Postpartum Depression (PPD)

A Mobile Application for Early Detection and Symptoms Trajectories of Postpartum Depression Using Ecological Momentary Assessment (EMA)

NCT07382336 · Postpartum Depression (PPD)

Clinical Validation of a Predictive Test for Postpartum Depression

NCT06831968 · Postpartum Depression (PPD), Pregnancy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 6, 2023Terms

Trial snapshot

StatusWITHDRAWN

Phase—

Enrollment—

Start dateFeb 2023

Last updatedMay 6, 2023

Condition

Postpartum Depression

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 6, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions